Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1349531rdf:typepubmed:Citationlld:pubmed
pubmed-article:1349531lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:1349531lifeskim:mentionsumls-concept:C0330390lld:lifeskim
pubmed-article:1349531lifeskim:mentionsumls-concept:C0021758lld:lifeskim
pubmed-article:1349531lifeskim:mentionsumls-concept:C0025255lld:lifeskim
pubmed-article:1349531lifeskim:mentionsumls-concept:C0004561lld:lifeskim
pubmed-article:1349531lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:1349531lifeskim:mentionsumls-concept:C0020846lld:lifeskim
pubmed-article:1349531lifeskim:mentionsumls-concept:C0034790lld:lifeskim
pubmed-article:1349531lifeskim:mentionsumls-concept:C0085246lld:lifeskim
pubmed-article:1349531lifeskim:mentionsumls-concept:C1332714lld:lifeskim
pubmed-article:1349531lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:1349531lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:1349531lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:1349531lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:1349531lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:1349531lifeskim:mentionsumls-concept:C0150312lld:lifeskim
pubmed-article:1349531pubmed:issue5lld:pubmed
pubmed-article:1349531pubmed:dateCreated1992-6-5lld:pubmed
pubmed-article:1349531pubmed:abstractTextIn the present study it is demonstrated that human B cells can be induced to switch to IgE production following a contact-mediated signal provided by activated T cell receptor (TcR) gamma delta+, CD4+ and TcR alpha beta+, CD4+ T cell clones and interleukin (IL)-4. The signal provided by these T cell clones was antigen nonspecific, indicating that the TcR alpha beta/CD3 or TcR gamma delta/CD3 complexes were not involved in these T-B cell interactions. Activated TcR alpha beta+, CD8+, and TcR gamma delta+, CD4-CD8-, or resting CD4+ T cell clones were ineffective. Intact TcR alpha beta+ or TcR gamma delta+, CD4+ T cell clones could be replaced by plasma membrane-enriched fractions isolated from these activated CD4+ T cell clones. In contrast, membranes isolated from resting TcR alpha beta+, CD4+, TcR gamma delta+, CD4+ T cell clones or an Epstein-Barr virus (EBV)-transformed B cell line (EBV-LCL) failed to provide the costimulatory signal that, in addition to IL-4, is required for induction of IgE synthesis. As described for intact CD4+ T cells, CD4+ T cell membranes induced purified surface IgM+ B cells to switch to IgG4- and IgE- but not to IgA-producing cells, excluding the possibility of a preferential outgrowth of IgG4- and IgE-committed B cells. The membrane activity was inhibited by protease or heat treatment. Induction of IgE synthesis by B cells co-cultured with both TcR alpha beta+, CD4+ and TcR gamma delta+, CD4+ T cell clones and membrane preparations of these cells was blocked by anti-class II major histocompatibility complex (MHC) monoclonal antibodies (mAb), whereas various anti-CD4 mAb had differential blocking effects. Murine L cells, or EBV-LCL transfected with CD4 could not replace CD4+ T cell clones. These results indicate that, although CD4 and class II MHC antigens are required for productive CD4+ T cell clone-B cell interactions, an additional signal, provided by a membrane associated (glyco)protein that is induced by activation of both TcR alpha beta and TcR gamma delta, CD4+ T cells, is needed for induction of IgE production in the presence of IL-4.lld:pubmed
pubmed-article:1349531pubmed:languageenglld:pubmed
pubmed-article:1349531pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1349531pubmed:citationSubsetIMlld:pubmed
pubmed-article:1349531pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1349531pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1349531pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1349531pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1349531pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1349531pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1349531pubmed:statusMEDLINElld:pubmed
pubmed-article:1349531pubmed:monthMaylld:pubmed
pubmed-article:1349531pubmed:issn0014-2980lld:pubmed
pubmed-article:1349531pubmed:authorpubmed-author:SpitsHHlld:pubmed
pubmed-article:1349531pubmed:authorpubmed-author:KehryMMlld:pubmed
pubmed-article:1349531pubmed:authorpubmed-author:De VriesJ EJElld:pubmed
pubmed-article:1349531pubmed:authorpubmed-author:RoncaroloM...lld:pubmed
pubmed-article:1349531pubmed:authorpubmed-author:Van...lld:pubmed
pubmed-article:1349531pubmed:authorpubmed-author:GascanHHlld:pubmed
pubmed-article:1349531pubmed:authorpubmed-author:GauchatJ FJFlld:pubmed
pubmed-article:1349531pubmed:authorpubmed-author:YsselHHlld:pubmed
pubmed-article:1349531pubmed:authorpubmed-author:AversaG GGGlld:pubmed
pubmed-article:1349531pubmed:issnTypePrintlld:pubmed
pubmed-article:1349531pubmed:volume22lld:pubmed
pubmed-article:1349531pubmed:ownerNLMlld:pubmed
pubmed-article:1349531pubmed:authorsCompleteYlld:pubmed
pubmed-article:1349531pubmed:pagination1133-41lld:pubmed
pubmed-article:1349531pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1349531pubmed:meshHeadingpubmed-meshheading:1349531-...lld:pubmed
pubmed-article:1349531pubmed:meshHeadingpubmed-meshheading:1349531-...lld:pubmed
pubmed-article:1349531pubmed:meshHeadingpubmed-meshheading:1349531-...lld:pubmed
pubmed-article:1349531pubmed:meshHeadingpubmed-meshheading:1349531-...lld:pubmed
pubmed-article:1349531pubmed:meshHeadingpubmed-meshheading:1349531-...lld:pubmed
pubmed-article:1349531pubmed:meshHeadingpubmed-meshheading:1349531-...lld:pubmed
pubmed-article:1349531pubmed:meshHeadingpubmed-meshheading:1349531-...lld:pubmed
pubmed-article:1349531pubmed:meshHeadingpubmed-meshheading:1349531-...lld:pubmed
pubmed-article:1349531pubmed:meshHeadingpubmed-meshheading:1349531-...lld:pubmed
pubmed-article:1349531pubmed:meshHeadingpubmed-meshheading:1349531-...lld:pubmed
pubmed-article:1349531pubmed:meshHeadingpubmed-meshheading:1349531-...lld:pubmed
pubmed-article:1349531pubmed:meshHeadingpubmed-meshheading:1349531-...lld:pubmed
pubmed-article:1349531pubmed:year1992lld:pubmed
pubmed-article:1349531pubmed:articleTitleMembranes of activated CD4+ T cells expressing T cell receptor (TcR) alpha beta or TcR gamma delta induce IgE synthesis by human B cells in the presence of interleukin-4.lld:pubmed
pubmed-article:1349531pubmed:affiliationHuman Immunology Department, DNAX Research Institute, Palo Alto, CA 94304-1104.lld:pubmed
pubmed-article:1349531pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1349531pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1349531lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1349531lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1349531lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1349531lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1349531lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1349531lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1349531lld:pubmed